Jialu (Lulu) Wang

Jialu (Lulu) Wang began their professional career in 2015 as a Teaching Assistant at EF Education First. In 2017, they were a Summer Researcher at the State Key Laboratory of Molecular Oncology at Cancer Hospital Chinese Academy of Medical Sciences. In 2018, they were a Graduate Researcher at The Johns Hopkins University School of Medicine, where they worked on novel drug delivery methods using lipid nanoparticles to treat autoimmune disorders and manipulating T cells to minimize transplant rejections. In 2019, they joined Eurofins Lancaster Laboratories as a Scientist II, where they developed robust, reliable cell and molecular assays for clients under GMP condition. In 2021, they began their current role as a Senior Research Associate (In Vivo Pharmacology) at ReCode Therapeutics, where they design targetted mRNA lipid nanoparticle delivery studies via intravenous delivery or intrathecal delivery to the central nervous system, and conducts CNS tissue collection and processing for bioluminescent reading, immunofluorescent staining, or FACS assays.

Jialu (Lulu) Wang received a Master's degree in Biomedical Engineering from The Johns Hopkins University in 2019, having studied at Lehigh University from 2013 to 2017 in the field of IDEAS: Bioengineering and Chemistry. Jialu (Lulu) also holds certifications from Coursera, including Getting and Cleaning Data (2018), R Programming (2018), and The Data Scientist’s Toolbox (2018).